For the Inventor, By the Inventor

Enter assignee name

Collegeville, PA, United States of America

Rhone-Poulenc Rorer Pharmaceuticals Inc.

Calculating rank

USPTO Granted Patents = 111

CIPO Patents = 1

Trademarks = 2

Forward Citations = 2,671

Loading Chart...

Loading Chart...

156 inventors (with patents filed for the assignee):

Alfred P Spada (25 out of 52 patents)

Kent W Neuenschwander (14 out of 27 patents)

Paul E Persons (13 out of 35 patents)

4. Michael R Myers (13 out of 37 patents)

5. John R Regan (12 out of 51 patents)

6. Bruce F Molino (11 out of 22 patents)

7. Anthony C Scotese (10 out of 30 patents)

8. Scott I Klein (9 out of 21 patents)

9. Michael C Jaye (8 out of 14 patents)

10. Martin P Maguire (8 out of 24 patents)

11. Henry F Campbell (8 out of 89 patents)

12. Robert A Galemmo, Jr (7 out of 27 patents)

13. Wilson H Burgess (7 out of 22 patents)

14. William R Ewing (6 out of 85 patents)

15. Jane S Lebkowski (6 out of 20 patents)

Core Competencies:

Antithrombotic Peptides

EGF Inhibitors

Growth Factors

Squalene Synthase Inhibitors

Chiral Compounds

Adeno-Associated Virus

Protein Purification

Bone Growth Factors

Pharmaceutical Compositions

Bioactive Mimics

Inhibitory Compounds

Leukotriene Selectivity

111 patents: Sort by Forward Citations

1. 6187548 - Methods using human calcium sensor protein, fragments thereof and DNA encoding same (2001-02-13),

2. 6143508 - Device and process for cell capture and recovery (2000-11-07),

3. 6127550 - Stereospecific preparation of chiral 1-aryl-and (2000-10-03),

4. 6057369 - Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) (2000-05-02),

5. 6034093 - Substituted sulfonic acid (2000-03-07),

6. 5958918 - Substituted (sulfinic acid, sulfonic acid, sulfonylamino or (1999-09-28),

7. 5866685 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides (1999-02-02),

8. 5863888 - Human Bek Fibroblast growth factor receptor (1999-01-26),

9. 5861314 - Adeno-associated viral (AAV) liposomes and methods related thereto (1999-01-19),

10. 5861171 - Adeno-associated viral (AAV) liposomes and methods related thereto (1999-01-19),

11. 5849538 - DNA encoding human endothelial cell growth factors and plasmids (1998-12-15),

12. 5834441 - Adeno-associated viral (AAV) liposomes and methods related thereto (1998-11-10),

13. 5827826 - Compositions of human endothelial cell growth factor (1998-10-27),

14. 5807686 - Pluripotential quiescent stem cell population (1998-09-15),

15. 5795889 - Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF (1998-08-18),

Company Overview

Rhone-Poulenc Rorer Pharmaceuticals Inc., based in Collegeville, PA, specializes in the development and manufacturing of innovative pharmaceutical compounds. The company focuses on advanced therapeutic areas, particularly in antithrombotic peptides, EGF inhibitors, and growth factors. Their expertise extends to chiral compounds and adeno-associated virus technologies, emphasizing protein purification and bone growth factors. Rhone-Poulenc Rorer is committed to enhancing healthcare through cutting-edge research and development in the pharmaceutical sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

111 Patents

#2 in Collegeville, PA

#134 in Pennsylvania

#3,465 in US

#7,113 in the World

Collegeville, PA, United States of America

Rhone-Poulenc Rorer Pharmaceuticals Inc.

Forward Citations = 2,671

156 inventors:

Alfred P Spada (25 out of 52 patents)

Kent W Neuenschwander (14 out of 27 patents)

Paul E Persons (13 out of 35 patents)

4. Michael R Myers (13 out of 37 patents)

5. John R Regan (12 out of 51 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rhone-Poulenc Rorer Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/rhone-poulenc-rorer-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…